BACKGROUND: Elevated cortisol indicates stress and may be a risk factor for cognitive decline in aging. Genetic factors may influence individual vulnerability to the adverse effects of stress on cognitive function in aging. METHOD: The authors investigated whether the gene-environment interaction between the genotype for the apolipoprotein E gene (APOE) and cortisol predicted cognitive performance in older urban adults. Cross-sectional data were analyzed from a population-based sample of 50-70-year-old men and women. Cognitive performance, salivary cortisol levels, and APOE genotype were assessed in 962 subjects. Scores on 20 standard cognitive tests were combined into seven domain scores (language, processing speed, eye-hand coordination, executive functioning, verbal memory and learning, visual memory and learning, visuoconstruction). RESULTS: In adjusted models, while a higher cortisol level was associated with worse cognitive scores, the slopes of the adverse relations were steeper in persons with at least one APOE-epsilon4 allele. Effect sizes were large: for example, the effect of having one epsilon4 allele plus a cortisol area under the curve greater than the 75th percentile was equivalent to a decrease in language score expected from an age increase of 8.0 years (95% confidence interval=1.7-14.4), while having two epsilon4 alleles and a cortisol area under the curve greater than the 75th percentile was equivalent to an age increase of 33.4 years (95% CI=14.8-52.0). CONCLUSIONS: These data suggest that APOE genotype modifies cortisol's relations with cognitive functioning and that the epsilon4 allele increases vulnerability of the aging brain to adverse effects of stress.
BACKGROUND: Elevated cortisol indicates stress and may be a risk factor for cognitive decline in aging. Genetic factors may influence individual vulnerability to the adverse effects of stress on cognitive function in aging. METHOD: The authors investigated whether the gene-environment interaction between the genotype for the apolipoprotein E gene (APOE) and cortisol predicted cognitive performance in older urban adults. Cross-sectional data were analyzed from a population-based sample of 50-70-year-old men and women. Cognitive performance, salivary cortisol levels, and APOE genotype were assessed in 962 subjects. Scores on 20 standard cognitive tests were combined into seven domain scores (language, processing speed, eye-hand coordination, executive functioning, verbal memory and learning, visual memory and learning, visuoconstruction). RESULTS: In adjusted models, while a higher cortisol level was associated with worse cognitive scores, the slopes of the adverse relations were steeper in persons with at least one APOE-epsilon4 allele. Effect sizes were large: for example, the effect of having one epsilon4 allele plus a cortisol area under the curve greater than the 75th percentile was equivalent to a decrease in language score expected from an age increase of 8.0 years (95% confidence interval=1.7-14.4), while having two epsilon4 alleles and a cortisol area under the curve greater than the 75th percentile was equivalent to an age increase of 33.4 years (95% CI=14.8-52.0). CONCLUSIONS: These data suggest that APOE genotype modifies cortisol's relations with cognitive functioning and that the epsilon4 allele increases vulnerability of the aging brain to adverse effects of stress.
Authors: Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: Ge Li; Monique M Cherrier; Debby W Tsuang; Eric C Petrie; Elizabeth A Colasurdo; Suzanne Craft; Gerard D Schellenberg; Elaine R Peskind; Murray A Raskind; Charles W Wilkinson Journal: Neurobiol Aging Date: 2005-11-04 Impact factor: 4.673
Authors: Arun S Karlamangla; Burton H Singer; Joshua Chodosh; Bruce S McEwen; Teresa E Seeman Journal: Neurobiol Aging Date: 2005-11-08 Impact factor: 4.673
Authors: Jason J Radley; Anne B Rocher; Melinda Miller; William G M Janssen; Conor Liston; Patrick R Hof; Bruce S McEwen; John H Morrison Journal: Cereb Cortex Date: 2005-05-18 Impact factor: 5.357
Authors: J Persson; J Lind; A Larsson; M Ingvar; M Cruts; C Van Broeckhoven; R Adolfsson; L-G Nilsson; L Nyberg Journal: Neurology Date: 2006-04-11 Impact factor: 9.910
Authors: Jyme H Schafer; Thomas A Glass; Karen I Bolla; Margaret Mintz; Anne E Jedlicka; Brian S Schwartz Journal: J Am Geriatr Soc Date: 2005-03 Impact factor: 5.562
Authors: Mindy J Katz; Carol A Derby; Cuiling Wang; Martin J Sliwinski; Ali Ezzati; Molly E Zimmerman; Jessica L Zwerling; Richard B Lipton Journal: Alzheimer Dis Assoc Disord Date: 2016 Apr-Jun Impact factor: 2.703
Authors: Davide Bruno; Jay J Nierenberg; James C Ritchie; Michael W Lutz; Nunzio Pomara Journal: Psychoneuroendocrinology Date: 2011-07-30 Impact factor: 4.905
Authors: G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Lars Bäckman; Roger A Dixon Journal: Neuropsychology Date: 2014-12-01 Impact factor: 3.295
Authors: Matthew S Panizzon; Richard Hauger; Hong Xian; Eero Vuoksimaa; Kelly M Spoon; Sally P Mendoza; Kristen C Jacobson; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Jeanne M McCaffery; Michael J Lyons; William S Kremen; Carol E Franz Journal: Neurobiol Aging Date: 2013-12-27 Impact factor: 4.673
Authors: Ilan Dar-Nimrod; Benjamin P Chapman; John A Robbins; Anton Porsteinsson; Mark Mapstone; Paul R Duberstein Journal: Int J Geriatr Psychiatry Date: 2012-01-04 Impact factor: 3.485